Shortcomings by the Score at Chinese Drug Manufacturer, FDA Said

Drug Industry Daily
A A
The FDA cited a Chinese drug and API facility for a slew of violations of agency standards, based on an inspection of the company’s plant in Tianmen.

To View This Article:

Login

Subscribe To Drug Industry Daily